Emergent Biosolutions Inc. buy UBS Group AG
Start price
02.06.26
/
50%
€7.18
Target price
02.06.27
-
Performance (%)
-41.77%
Price
07.08.26
€4.18
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG for Emergent Biosolutions Inc. is performing very badly with a performance of -41.77%. This prediction currently runs until 02.06.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Emergent Biosolutions Inc. | -33.312% | -33.312% |
| iShares Core DAX® | 2.573% | 5.333% |
| iShares Nasdaq 100 | 4.858% | 0.449% |
| iShares Nikkei 225® | 5.590% | -0.586% |
| iShares S&P 500 | 3.250% | 2.500% |
Comments by UBS_Group_AG for this prediction
In the thread Emergent Biosolutions Inc. diskutieren
Emergent Biosolutions (EBS) had its "buy" rating reaffirmed by UBS Group AG.
Ratings data for EBS provided by MarketBeat